BNP Paribas Financial Markets
IMVT icon

BNP Paribas Financial Markets’s Immunovant IMVT Stock Holding History

BNP Paribas Financial Markets’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.31M Sell
334,557
-18,499
-5% -$479K 0.01% 1676
2025
Q4 		$8.97M Sell
353,056
-330,346
-48% -$7.37M 0.01% 1682
2025
Q3 		$11M Buy
683,402
+385,232
+129% +$6.24M 0.01% 1476
2025
Q2 		$4.77M Buy
298,170
+176,121
+144% +$2.66M ﹤0.01% 1895
2025
Q1 		$2.09M Buy
122,049
+36,848
+43% +$771K ﹤0.01% 2342
2024
Q4 		$2.11M Buy
+85,201
New +$2.42M ﹤0.01% 2331

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return